Urimon, study of blood and urine for health monitoring

Urimon, study of blood and urine for health monitoring - Urimon

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON54711

Enrollment

12000

Registered

2018-10-16

Start date

2019-04-03

Completion date

Unknown

Last updated

2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

organ diseases including cancer, cardiovascular diseases and nervous system diseases organ diseases including cancer, cardiovascular diseases and nervous system diseases

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: normal health, between 45 and 75 years of age people with a known predisposition for diseases of interest between 30 and 75 years of age

Exclusion criteria

Exclusion criteria: currently suffering from a form of cancer, cardiovascular disease or neurodegenerative disease

Design outcomes

Primary

Measure	Time frame
• microRNA profiles derived from NGS of the small RNA fractions of blood and urine. • Sets of differentially expressed microRNAs in samples from people that developed high-incidence forms of cancer, cardiovascular disease or liver disease. • Longitudinal expression patterns of disease associated microRNAs in sample series from individuals that developed these diseases.	—

Countries

Netherlands

Contacts

Public ContactJ Rooij

You2Yourself BV

info@urimon.nl088 0220268

Outcome results